The protein data bank and structural genomics. Westbrook, J., Feng, Z., Chen, L., Yang, H. Gerstein, M., Edwards, A., Arrowsmith, C. Structural genomics of Mycobacterium tuberculosis: a preliminary report of progress at UCLA. Rational protein crystallization by mutational surface engineering. Patterns of protein-fold usage in eight microbial genomes: A comprehensive structural census. Medium-scale structural genomics: strategies for protein expression and crystallization. Protein production in Escherichia coli for structural studies by XвЂ“ray crystallography. Structural genomics of the Thermotoga maritima proteome implemented in a high-throughput structure determination pipeline. Tapping DNA for structures produces a trickle. A global representation of the protein fold space. Validation of antibacterial mechanism of action using regulated antisense RNA expression in Staphylococcus aureus. & Labischinski, H.) 61вЂ“68 (Springer Verlag, Berlin, 1997). in Antibacterial Therapy: Achievements, Problems and Future Perspectives (eds Busse, W. An array of target-specific screening strains for antibacterial discovery. Discovery of a novel and potent class of FabI-directed antibacterial agents. Regulated gene expression in Staphylococcus aureus for identifying conditional lethal phenotypes and antibiotic mode of action. New assay technologies for highвЂ“throughput screening. High-throughput screening: advances in assay technologies. A genome-wide strategy for the identification of essential genes in Staphylococcus aureus. Experimental determination and system level analysis of essential genes in Escherichia coli MG1655. Comprehensive transposon mutant library of Pseudomonas aeruginosa. A genome-scale analysis for identification of genes required for growth or survival of Haemophilus influenzae. A global approach to identify novel broad-spectrum antibacterial targets among proteins of unknown function. Whole-genome random sequencing and assembly of Haemophilus influenzae Rd. Structure-based design of agents targeting the bacterial ribosome. coli complexed with one of the most potent coumarin inhibitors, clorobiocin. The high-resolution crystal structure of a 24-kDa gyrase B fragment from E. Crystal structures of Escherichia coli topoisomerase IV ParE subunit (24 and 43 kilodaltons): a single residue dictates differences in novobiocin potency against topoisomerase IV and DNA gyrase. Structural basis for the ОІ-lactam resistance of PBP2a from methicillin-resistant Staphylococcus aureus. Structural basis of transcription initiation: RNA polymerase holoenzyme at 4 Г… resolution. The complete atomic structure of the large ribosomal subunit at 2.4 Г… resolution. Crystal structure of the ribosome at 5.5 Г… resolution. The impact of structure-guided drug design on clinical agents. Recent strategies in the search for new anti-influenza therapies.

Analytic solver platform psitarget